{
  "id": "cluster_5_doc4",
  "content": "Mountain View Tribune health section (May 2023) featured Valley Genomics' research on early-onset mitochondrial disorders. Study participants with POLG mutations showed 60% response rate to targeted antioxidant therapy. Article mentions insurance barriers for genetic testing despite clinical guidelines recommending early diagnosis.",
  "metadata": {
    "format": "news_article"
  }
}